Cipla Limited has announced its earnings conference call schedule for the fourth quarter of fiscal year 2026, providing investors and stakeholders with an opportunity to engage with the company's leadership team regarding its financial performance.

Conference Call Details

The pharmaceutical company has scheduled the earnings conference call for May 13, 2026, with comprehensive timing arrangements to accommodate global participants:

Regulatory Compliance and Purpose

The announcement was made on April 16, 2026, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The conference call is specifically designed to discuss the company's Q4FY26 audited financial results, allowing the leadership team to present key financial metrics and respond to investor queries.

Access Information

Cipla has provided multiple access options for participants across different regions:

Additional Resources

Following the conference call, a complete transcript will be made available on the company's official website at www.cipla.com . For investor-related inquiries, participants can contact Diksha Maheshwari from the Investor Relations team at Investor.Relations@cipla.com .

Corporate Communication

The formal notification was signed by Rajendra Chopra, Company Secretary of Cipla Limited, ensuring proper corporate governance protocols were followed in the announcement process.

Cipla Limited has issued an important notice to its shareholders regarding the IEPFA Second 100-Day Campaign - 'Saksham Niveshak', aimed at facilitating dividend claims and KYC updates. The pharmaceutical company published newspaper advertisements on April 15, 2026, in leading publications to ensure maximum reach to its shareholder base.

Regulatory Compliance and Publication Details

The notice was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company published advertisements in Business Standard (English) and Sakal (Marathi) newspapers on April 16, 2026, ensuring compliance with regulatory requirements for shareholder communication.

Campaign Objectives and Shareholder Benefits

The 'Saksham Niveshak' campaign represents the second phase of the 100-day initiative designed to help shareholders claim their unclaimed dividends and update their KYC (Know Your Customer) information. This initiative is particularly important for shareholders who may have unclaimed dividends or require documentation updates to maintain their investment records.

Appointed Service Agencies

Cipla has appointed two specialized agencies to assist shareholders with their claims and documentation processes:

Documentation and Process Information

The company has made detailed information available on its website under the 'Corporate Governance' section, specifically in the 'Investor Service Forms' subsection. Shareholders can access the applicable ISR (Investor Service Request) forms and other necessary documentation through the company's official website.

Stock Exchange Communication

The notice was formally communicated to major stock exchanges including BSE Limited (Scrip Code: 500087), National Stock Exchange of India Limited (Scrip Code: CIPLA), and Societe de la Bourse de Luxembourg. This ensures comprehensive regulatory compliance across all trading platforms where Cipla shares are listed.

The document was signed by Rajendra Chopra, Company Secretary, and dated April 16, 2026, from Mumbai, demonstrating the company's commitment to transparent shareholder communication and regulatory compliance.